Assurance Infusion recalls hydromorphone 4mg/ml injection in 20mL syringes due to lack of sterility assurance. Affected lots: 12182019@6, expiring 12/27/2019.
Lack of sterility assurance.
Assurance Infusion is recalling hydromorphone 4mg/ml injection in 20mL syringes because they may not be sterile. This could lead to infections if used improperly.
The syringes lack sterility assurance, meaning they might be contaminated with bacteria. If injected, this could cause serious infections like sepsis in patients.
Patients using this medication for pain management are affected. Healthcare providers administering the drug are at higher risk due to the potential for infection.
Check for the lot number 12182019@6 on the syringe packaging. The expiration date is December 27, 2019. This product was sold by Assurance Infusion.
Discard the syringe immediately if it has the lot number 12182019@6.
The recall states the syringes lack sterility assurance, so they are not safe to use.
Discard the syringe immediately if it has the lot number 12182019@6.
The recall was issued by Assurance Infusion with the lot number 12182019@6, expiring December 27, 2019.
We’ve drafted a message you can send Assurance Infusion to request your refund or repair — edit it as you like.
Subject: Recall D-0745-2020 — Assurance Infusion Assurance Infusion Hello, I own a Assurance Infusion that is covered by recall D-0745-2020 from Assurance Infusion. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
